Back

Short‑ and long‑term efficacy of oral stabilized bivalent liposomal iron versus intravenous ferric carboxymaltose in chronic heart failure patients: is there a difference?

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: New analyses and usage of old drugs Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ercole Tagliamonte

Hospital Umberto I, Nocera Inferiore (Italy)

5 More presentations in this session

Presentation thumbnail
Effect of empagliflozin on adenosine triphosphate levels in vivo in patients with type 2 diabetes mellitus combined with heart failure
Miss U. Omurzakova (Bishkek, KG)
Abstract
Presentation thumbnail
Vericiguat and cardiovascular outcomes in heart failure revisited: a bayesian reanalysis of 12,877 patients
Mr P. Batista (BR)
Abstract
Presentation thumbnail
Ambulatory milrinone in advanced heart failure: a single-center comparison of continuous and intermittent infusion strategies
Doctor A. Rioux (Quebec, CA)
Abstract
Presentation thumbnail
Long‑acting efficacy of oral stabilized bivalent liposomal iron therapy on iron balance and quality of life in chronic heart failure: more than iron supplementation
Doctor E. Tagliamonte (Nocera Inferiore, IT)
Abstract
Presentation thumbnail
Effects of low-dose dapagliflozin on heart failure–related outcomes in patients with heart failure and type 2 diabetes: a subanalysis of the dapper study
Doctor S. Ito (Osaka, JP)
Abstract

Access the full session

Session thumbnail
New analyses and usage of old drugs

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?
1 September 2025
thumbnail
Congress Presentation
Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes
15 March 2025
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025
thumbnail
Congress Presentation
Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources